Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in the fields of assay development, lab automation, Ultra-High-Throughput Screening (uHTS) and hit-to-lead biological profiling, in order to find novel leads for drug development. PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences. We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community. Through this we help you accelerate drug discovery for a healthier society.
Optimal Assay conditions? Does that exist?
The COVID-19 lead discovery project at PPSC started by identifying a well-established target that governs viral entry into host cells.
In a paper recently published in the SLAS Discovery Journal of Biomolecular Screening, European Lead Factory (ELF) scientists from Pivot
Webinar: Hit discovery for trained immunity and tolerance
Register now Hit discovery against epigenetic targets Join this webinar to learn about: Trained immunity. The role of epigenetic targets
ZeGlobalTox – a rapid and reliable preclinical screening tool
The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park – RE2423
Industrielaan 63
5349 AE Oss
The Netherlands
